Halozyme Therapeutics Inc
![Halozyme Therapeutics Inc](https://api.admiralmarkets.com/trade_icons/bright-128/HALO.png)
Closed
Sector Healthcare
59.21 -2.85
Overview
Share price change
24h
Min
59.01
Max
59.43
Income | 16M 93M |
---|---|
Sales | 35M 231M |
P/E Sector Avg | 21.73 103.001 |
EPS | 0.91 |
Profit margin | 40.366 |
Employees | 373 |
EBITDA | 22M 143M |
Recommendations | Buy |
---|---|
12 Months Forecast | +1.89 upside |
Next Earnings | 4 Nov 2024 |
---|
Market Cap | 262M 8.1B |
---|---|
Previous open | 62.06 |
Previous close | 59.21 |
News Sentiment
By Acuity
50%
50%
114 / 365 Healthcare
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Halozyme Therapeutics Inc Chart
Related News
Peer Comparison
Price change
Halozyme Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 60.33 USD 1.89%
High 72 USD
Low 51 USD
Based on 10 Wall Street analysts offering 12 month price targets forHalozyme Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$